MARKET

SMNR

SMNR

Semnur Pharmaceuticals Inc.
OTCPK
0.670
-0.130
-16.23%
Closed 15:58 08/14 EDT
OPEN
0.655
PREV CLOSE
0.800
HIGH
0.800
LOW
0.655
VOLUME
4.81K
TURNOVER
3.66K
52 WEEK HIGH
25.00
52 WEEK LOW
0.150
MARKET CAP
154.26M
P/E (TTM)
-1.4325
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SMNR last week (0803-0807)?
Weekly Report · 5d ago
Weekly Report: what happened at SMNR last week (0727-0731)?
Weekly Report · 08/03 10:10
Weekly Report: what happened at SMNR last week (0720-0724)?
Weekly Report · 07/27 10:14
Weekly Report: what happened at SMNR last week (0713-0717)?
Weekly Report · 07/20 10:11
Weekly Report: what happened at SMNR last week (0706-0710)?
Weekly Report · 07/13 10:13
Semnur Pharmaceuticals announces $100M strategic equity investment
TipRanks · 07/07 14:57
Semnur Pharmaceuticals signs binding term sheet for $100M equity investment from iHolding Group
Seeking Alpha · 07/07 10:36
Scilex Portfolio Company Semnur Pharmaceuticals Receives $100M Investment From iHolding In 10M Newly Issued Shares At $10 Per Share
Benzinga · 07/07 10:05
More
About SMNR
Semnur Pharmaceuticals, Inc. is a clinical-late stage specialty pharmaceutical company focused on the development and commercialization of non-opioid pain therapies. The Company's lead program, SP-102, is non-opioid gel formulation administered epidurally in development for patients with moderate to severe chronic radicular pain/sciatica. It is developing SP-102 to address problems associated with corticosteroid products that are used in practice but not approved for epidural injection or the treatment of sciatica. SP-102 is a Phase III sterile dexamethasone sodium phosphate viscous gel formulation of 10 mg dexamethasone at a 5 mg/mL concentration in a pre-filled glass syringe for delivery via an epidural injection. SP-102 allows for use of potent dexamethasone and provides for longer residency time at the site of injection through the use of a viscous excipient in lieu of particulates. The product is formulated without the use of preservatives and packaged in a pre-filled syringe.

Webull offers Semnur Pharmaceuticals Inc stock information, including OTCPK: SMNR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMNR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SMNR stock methods without spending real money on the virtual paper trading platform.